Health Observer Bermuda: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Observer Bermuda.

Press releases published on June 18, 2026

Jun. 18, 2026

Essential Pharma appoints Becki Morison as Chief Executive Officer

Indeterminate GlobeNewswire

Jun. 18, 2026

VERAXA Biotech Establishes in vitro Proof-of-Concept for Novel BiTAC-ADC Technology Platform and Launches Partnering Discussions at BIO International Convention 2026

Indeterminate GlobeNewswire

Jun. 18, 2026

Nephros to Host Virtual Investor Event: “Beyond Filtration: The Nephros Model in Action”

Indeterminate GlobeNewswire

Jun. 18, 2026

Beam Therapeutics Announces Clearance of Investigational New Drug Application for BEAM-304 for the Treatment of Phenylketonuria (PKU) by the United States (U.S.) Food and Drug Administration

Indeterminate GlobeNewswire

Jun. 18, 2026

Grey Matters Announces Increase to Private Placement Financing to $1.25 Million and Closing of Offering

Indeterminate GlobeNewswire

Jun. 18, 2026

Hi*Ball Energy Arrives in the UK, Leading a New Wave of Clean Energy

Indeterminate GlobeNewswire

Jun. 18, 2026

Axsome Therapeutics Highlights the Importance of Brain Health During Alzheimer's & Brain Awareness Month

Indeterminate GlobeNewswire

Jun. 18, 2026

Asimov Announces Strategic Partnership with the Rosalind & Morris Goodman Cancer Institute at McGill University to Advance Next-Generation Biologics

Indeterminate GlobeNewswire

Jun. 18, 2026

CervoMed Secures New U.S. Patent Protecting Use of Neflamapimod in Pure Dementia with Lewy Body Patients into 2042

Indeterminate GlobeNewswire

Jun. 18, 2026

Alturos Therapeutics advancement of lead candidate ALT0135, a potentially first-in-class, orally bioavailable small molecule, into IND-enabling studies

Indeterminate GlobeNewswire

Jun. 18, 2026

Alvotech Announces Closing of Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares, Raising an Aggregate of $165 Million with Concurrent Private Placement

Indeterminate GlobeNewswire

Jun. 18, 2026

Mallia Aesthetics Reports Positive Results from Consumer Study with its Hormone-Free 8T3 Essentials Hair Serum

Indeterminate GlobeNewswire

Jun. 18, 2026

New analyses from FIBRONEER™ trials suggest survival benefit with nerandomilast in IPF and PPF

Indeterminate GlobeNewswire

Jun. 18, 2026

Alvotech Announces Proposed $125 Million Public Offering and Concurrent Private Placement of Ordinary Shares

Indeterminate GlobeNewswire

Jun. 18, 2026

BIO-Europe unveils renewed vision as the must-attend global biopharma strategy forum

Indeterminate GlobeNewswire

Jun. 18, 2026

Nicox Announces Positive Pre-submission Regulatory Feedback in China Supporting NDA filing for NCX 470

Indeterminate GlobeNewswire

Jun. 18, 2026

Nicox annonce des retours réglementaires préalables positifs en Chine soutenant le dépôt du NDA pour NCX 470

Indeterminate GlobeNewswire

Jun. 18, 2026

F2G and Shionogi Announce Positive Topline Results From Global Phase 3 OASIS Study Evaluating Oral Olorofim Versus AmBisome® Followed by Standard of Care in Patients With Invasive Aspergillosis

Indeterminate GlobeNewswire

Jun. 18, 2026

Legend Biotech Corporation Announces Pricing of Public Offering

Indeterminate GlobeNewswire